· investment-strategies · 1 min read
Notation Capital Backs Photon Health $16M Series A
Notation Capital backed Photon Health’s $16M Series A, a follow-on to its earlier lead, staying true to its NYC pre-seed roots.
Notation Capital backed Photon Health’s $16M Series A in April 2026 — a follow-on to its earlier lead in the company — reflecting the firm’s first-check-and-follow-on model.
Key facts
- Investor: Notation Capital (co-investor; earlier Series A lead)
- Company: Photon Health
- Round: $16M Series A
- Date: April 2026
- Firm: First dedicated NYC pre-seed fund (founded 2015)
Why this matters
Photon Health shows Notation Capital supporting a technical team from its first institutional check through growth, consistent with its concentrated, founder-obsessed pre-seed strategy.
Sources
- Notation Capital / Photon Health (CB Insights): https://www.cbinsights.com/investor/notation-capital
- Notation Capital portfolio (Caplight): https://www.caplight.com/investor/notation-vc
Share: